Is KVPBQ.PK a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

150 people get KVPBQ.PK articles and Market Currents by email alert.

Get email alerts on KVPBQ.PK »

HEADLINES:

KV Pharmaceutical: FDA Issues New Update On Makena
Mike Young • Mon, Jun 18, 2012 • 11 Comments
Columbia Labs Shares Are A Speculative Buy Here
GuruFundPicks • Tue, Jan 24, 2012 • 3 Comments
Finding Opportunities Among Tuesday's Big News Movers
GuruFundPicks • Wed, Jan 18, 2012 • 5 Comments
Trade Ideas From Last Week's Big Biotech News Movers
GuruFundPicks • Mon, Nov 21, 2011
KV Pharmaceuticals Facing Difficulty Overcoming Negative Sentiment Even With A New FDA Investigation
M. E. Garza • Thu, Nov 17, 2011 • 1 Comment
Amgen To Cut 380 R&D Jobs: Biotech's Weekly Round-Up Of Mishaps
The Burrill Report • Sun, Oct 23, 2011
Times They Are A Changin' - Your Investment Strategy Should Not
Marc Lichtenfeld • Sun, Oct 23, 2011 • 8 Comments
The Case For Highly Speculative Biotechs
Bill Maurer • Wed, Sep 21, 2011 • 10 Comments
Will the Next Apple or Google Be Found Among These Micro Caps?
Kurtis Hemmerling • Thu, Aug 18, 2011 • 9 Comments
Feds Will Not Ban Forest CEO From Health Programs
Pharmalot • Mon, Aug 8, 2011
7 Super Speculative Stocks to Watch
NakedValue • Mon, Jun 27, 2011 • 9 Comments
KV Pharmaceutical: Surging Revenue and New Product Launch May Signal Turnaround
Mike Young • Fri, Jun 24, 2011 • 12 Comments
Beach Point Capital's Favorite Stock Picks
Insider Monkey • Wed, Jun 22, 2011 • 3 Comments
3 Cheap Stocks Set for a Big Rebound
StreetAuthority • Thu, Apr 21, 2011
KV Pharma Lowers Price of Preemie Drug
Pharmalot • Fri, Apr 1, 2011 • 7 Comments
Cramer's Lightning Round - MarkWest Energy Is For Real (3/30/11)
SA Editor Miriam Metzinger • Thu, Mar 31, 2011
KV Pharmaceuticals and Makena: The FDA's Move
Derek Lowe • Thu, Mar 31, 2011 • 8 Comments
KV Pharmaceuticals' Pricing for Makena
Derek Lowe • Thu, Mar 24, 2011 • 18 Comments
KV Pharmaceuticals Under Federal Scrutiny for Price Gouging
Pharmalot • Sat, Mar 19, 2011 • 28 Comments
KV Pharmaceuticals Gets Away With Pricing on Makena
Derek Lowe • Fri, Mar 11, 2011 • 11 Comments

To learn more about Seeking Alpha Pro, click here.

KV Pharmaceutical: FDA Issues New Update On Makena
Mike Young • Mon, Jun 18, 2012 • 11 Comments
KV Pharmaceuticals Facing Difficulty Overcoming Negative Sentiment Even With A New FDA Investigation
M. E. Garza • Thu, Nov 17, 2011 • 1 Comment
KV Pharmaceutical: Surging Revenue and New Product Launch May Signal Turnaround
Mike Young • Fri, Jun 24, 2011 • 12 Comments
KV Pharma Lowers Price of Preemie Drug
Pharmalot • Fri, Apr 1, 2011 • 7 Comments
KV Pharmaceuticals and Makena: The FDA's Move
Derek Lowe • Thu, Mar 31, 2011 • 8 Comments
KV Pharmaceuticals' Pricing for Makena
Derek Lowe • Thu, Mar 24, 2011 • 18 Comments
KV Pharmaceuticals Under Federal Scrutiny for Price Gouging
Pharmalot • Sat, Mar 19, 2011 • 28 Comments
KV Pharmaceuticals Gets Away With Pricing on Makena
Derek Lowe • Fri, Mar 11, 2011 • 11 Comments
KV Pharmaceutical Overvalued?
Michael Bryant • Tue, Feb 8, 2011 • 36 Comments

Columbia Labs Shares Are A Speculative Buy Here
GuruFundPicks • Tue, Jan 24, 2012 • 3 Comments
Finding Opportunities Among Tuesday's Big News Movers
GuruFundPicks • Wed, Jan 18, 2012 • 5 Comments
Trade Ideas From Last Week's Big Biotech News Movers
GuruFundPicks • Mon, Nov 21, 2011
Amgen To Cut 380 R&D Jobs: Biotech's Weekly Round-Up Of Mishaps
The Burrill Report • Sun, Oct 23, 2011
Times They Are A Changin' - Your Investment Strategy Should Not
Marc Lichtenfeld • Sun, Oct 23, 2011 • 8 Comments
The Case For Highly Speculative Biotechs
Bill Maurer • Wed, Sep 21, 2011 • 10 Comments
Will the Next Apple or Google Be Found Among These Micro Caps?
Kurtis Hemmerling • Thu, Aug 18, 2011 • 9 Comments
Feds Will Not Ban Forest CEO From Health Programs
Pharmalot • Mon, Aug 8, 2011
7 Super Speculative Stocks to Watch
NakedValue • Mon, Jun 27, 2011 • 9 Comments
Beach Point Capital's Favorite Stock Picks
Insider Monkey • Wed, Jun 22, 2011 • 3 Comments
3 Cheap Stocks Set for a Big Rebound
StreetAuthority • Thu, Apr 21, 2011
Cramer's Lightning Round - MarkWest Energy Is For Real (3/30/11)
SA Editor Miriam Metzinger • Thu, Mar 31, 2011
KV Pharmaceutical Jumps Over 30% but Bristol-Myers Is the Better Bet
Robert Weinstein • Wed, Mar 9, 2011 • 20 Comments
Contrarian Value Portfolio Update
Greenbackd • Thu, Sep 16, 2010 • 6 Comments
Trading Off of the FDA
Mike Havrilla • Wed, Jul 14, 2010 • 1 Comment
Russell 2000's Most Attractive Stocks
Value Expectations • Mon, Apr 26, 2010
Drug Pipeline Pulse Check: Teva on a Tear
Research Recap • Tue, Apr 6, 2010
Tiny Titans Portfolio: 200 Day Benchmark
Scott's Investments • Sun, Feb 21, 2010 • 3 Comments
Tiny Titan Stocks
Scott's Investments • Fri, Feb 19, 2010
The Market Bullies Small Caps
David Brown • Tue, Oct 27, 2009 • 5 Comments

There are no Transcripts on KVPBQ.PK.

There are no News articles on KVPBQ.PK.

KVPBQ.PK vs. ETF Alternatives

Company Description

Currently, there's no company description for KVPBQ.PK.

Sector: Healthcare

Industry: Drug Delivery & Accessories

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Sunday, August 5, 2012, 5:46 AM K-V Pharmaceutical (KV.A) filed for bankruptcy protection yesterday, citing the FDA's failure to enforce orphan drug marketing exclusivity for the Missouri firm's Makena drug for helping prevent premature births. This included enabling some state Medicaid agencies to limit access to the treatment. K-V also blamed manufacturing and marketing restrictions on some of its other products. (PR) Comment! [Healthcare]
Friday, July 6, 2012, 11:46 AM K-V Pharmaceutical (KV.A -16.8%) tanks after saying it's filed a lawsuit against the FDA for failing to crack down on compounded versions of its premature birth drug Makena. Pharmacies have been using the active ingredient hydroxyprogesterone, which does not have a formal FDA clearance, to compound cheaper versions of Makena, an injectable hormonal medicine that reduces the risk of pre-term birth in pregnant women with a history of early deliveries. 1 Comment [Healthcare, On the Move]
Monday, June 18, 2012, 9:57 AM The FDA says its analysis of compounded versions of the active ingredient in K-V Pharmaceuticals’ (KV.A -16.2%) Makena premature-birth prevention drug did not identify any major safety problems, but the agency reiterates that approved drugs are generally safer and more effective than compounded products. Comment! [Healthcare, On the Move]
Monday, January 23, 2012, 8:17 AM Columbia Labs (CBRX) -52.5% premarket after trading was suspended all day Friday following the FDA's negative vote on the company's Prochieve drug candidate. Partner Watson Pharmaceutials (WPI) is little changed after falling 3.5% on Friday. Rival K-V (KV.A) +1.9% after Friday's 9.3% gain. Comment! [Healthcare, On the Move]
Friday, January 20, 2012, 3:17 PM Shares of K-V Pharmaceutcial (KV.A +10.4%) rally as rival Columbia Laboratories (CBRX) gets raked over the coals by the FDA in a review of its preterm birth gel that ends up concluding the firm's data isn't sufficient. (previous: I, II). Trading on CBRX still halted. Comment! [On the Move, Healthcare]
Tuesday, January 17, 2012, 2:08 PM Shares of K-V Pharmaceutical (KV.A +16.9%) soar after rival Columbia Laboratories' preterm birth gel is deemed "not effective" by the FDA. Also showing some action related to the news is Watson Pharmaceuticals (WPI -2.6%). Comment! [On the Move, Healthcare]
Friday, September 25, 2009, 9:00 AM Premarket gainers: ALTH +11%. SLE +7.5%. LCC +4%. AIB +4%.
Losers: RIMM -14%. KV.A -12%. KBH -6%. NMR -5%. Comment!

Michael Bryant
Notice the correlation between KVPBQ.PK and KV.B. http://yhoo.it/H4VV66
3/26/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
LOL! I am lucky! Someone asked me the other day about biotechs under $3 and I said to look into BPAX & KVPBQ.PK, which ended today up 41% & 11%.
2/6/12
Reply (11)

• !Report Abuse
View all 11 replies
Michael Bryant: Um............my profile said I graduated. And didn't I disclose how much I make a few weeks ago. Prove me wrong.
2/6/12
• !Report Abuse
AlphaVolume: ADVISOR....
2/6/12
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Watch K-V Pharmaceutical (KVPBQ.PK) and its claim on rivals' pills. Could be a boom for the stock. http://bit.ly/s5ZstY
11/14/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
KV Pharmaceutical (KVPBQ.PK) storming back after correction.
3/23/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Robert Weinstein
$KVPBQ.PK I am shorting in premarket trading above 13.19. So far I have been able to add some to my short
3/9/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Robert Weinstein
$KVPBQ.PK holding short into tomorrow. Just did the numbers and this one is way overbought. Not even going to be profitable this year
3/8/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

malonjao05
KVPBQ.PK marking for only fda approved drug to stop pre-mature birth begins
3/8/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Robert Weinstein
shorting $KVPBQ.PK KVPBQ.PK at $13.15 and higher for next 20 mins with profit target of 35 cents
3/8/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Robert Weinstein
shorting $KVPBQ.PK "KV A" KY Pharma at 12.34 and higher with a profit target of 35 cents of ave
3/8/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

stewms7
When should I pull the trigger on KVPBQ.PK pharm?
2/16/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Michael Bryant
LOL! I am lucky! Someone asked me the other day about biotechs under $3 and I said to look into BPAX & KVPBQ.PK, which ended today up 41% & 11%.
2/6/12
Reply (11)

• !Report Abuse
View all 11 replies
Michael Bryant: Um............my profile said I graduated. And didn't I disclose how much I make a few weeks ago. Prove me wrong.
2/6/12
• !Report Abuse
AlphaVolume: ADVISOR....
2/6/12
• !Report Abuse
Add a reply...

140 characters

KVPBQ.PK K-V Pharmaceutical Co.

KVPBQ.PK

K-V Pharmaceutical Co.